Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Diabetes | Research

Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach

Authors: Ernesto Martín-Núñez, Miriam Goñi-Olóriz, Lara Matilla, Mattie Garaikoetxea, Laura Mourino-Alvarez, Adela Navarro, Amaya Fernández-Celis, Ibai Tamayo, Alicia Gainza, Virginia Álvarez, Rafael Sádaba, María G. Barderas, Eva Jover, Natalia López-Andrés

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

Diabetes mellitus (DM) accelerates the progression of aortic stenosis (AS), but how their underlying molecular mechanisms interact is not clear. Moreover, whether DM contributes to clinically relevant sex-differences in AS is unknown. In this work we aim to characterize the sex-specific profile of major pathological mechanisms fundamental to aortic valve (AV) degeneration in AS patients with or without concomitant DM.

Methods

283 patients with severe AS undergoing surgical valve replacement (27.6% DM, 59.4% men) were recruited. Expression of pathological markers related to AS were thoroughly assessed in AVs and valve interstitial cells (VICs) according to sex and presence of DM. Complementary in vitro experiments in VICs in the presence of high-glucose levels (25 mM) for 24, 48 and 72 h were performed.

Results

Oxidative stress and metabolic dysfunction markers were increased in AVs from diabetic AS patients compared to non-diabetic patients in both sexes. However, disbalanced oxidative stress and enhanced inflammation were more predominant in AVs from male AS diabetic patients. Osteogenic markers were exclusively increased in the AVs of diabetic women. Basal characterization of VICs confirmed that oxidative stress, inflammation, calcification, and metabolic alteration profiles were increased in diabetic VICs with sex-specific differences. VICs cultured in hyperglycemic-like conditions triggered inflammatory responses in men, whereas in women rapid and higher production of pro-osteogenic molecules.

Conclusions

DM produces sex-specific pathological phenotypes in AV of AS patients. Importantly, women with diabetes are more prone to develop AV calcification. DM should be considered as a risk factor in AS especially in women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, et al. Poor long-term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74:1851–63.CrossRefPubMed Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, et al. Poor long-term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74:1851–63.CrossRefPubMed
2.
go back to reference Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18:853–64.CrossRefPubMed Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18:853–64.CrossRefPubMed
3.
go back to reference Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, et al. Aortic valve stenosis. Arterioscler Thromb Vasc Biol. 2020;40:885–900.CrossRefPubMed Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, et al. Aortic valve stenosis. Arterioscler Thromb Vasc Biol. 2020;40:885–900.CrossRefPubMed
4.
go back to reference Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632.CrossRefPubMed Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632.CrossRefPubMed
5.
go back to reference Yetkin E, Waltenberger J. Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol. 2009;135:4–13.CrossRefPubMed Yetkin E, Waltenberger J. Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol. 2009;135:4–13.CrossRefPubMed
6.
go back to reference Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al. Initial Surgical Versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827–38.CrossRefPubMed Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al. Initial Surgical Versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827–38.CrossRefPubMed
7.
go back to reference Singh A, Greenwood JP, Berry C, Dawson DK, Hogrefe K, Kelly DJ, et al. Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic importance of MIcrovascular dysfunction in aortic stenosis (PRIMID AS) study. Eur Heart J. 2017;38:1222–9.CrossRefPubMedPubMedCentral Singh A, Greenwood JP, Berry C, Dawson DK, Hogrefe K, Kelly DJ, et al. Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic importance of MIcrovascular dysfunction in aortic stenosis (PRIMID AS) study. Eur Heart J. 2017;38:1222–9.CrossRefPubMedPubMedCentral
8.
go back to reference Ljungberg J, Johansson B, Engström KG, Albertsson E, Holmer P, Norberg M et al. Traditional Cardiovascular Risk factors and their relation to future surgery for Valvular Heart Disease or Ascending Aortic Disease: a case–referent study. J Am Heart Assoc. 2017;6. Ljungberg J, Johansson B, Engström KG, Albertsson E, Holmer P, Norberg M et al. Traditional Cardiovascular Risk factors and their relation to future surgery for Valvular Heart Disease or Ascending Aortic Disease: a case–referent study. J Am Heart Assoc. 2017;6.
9.
go back to reference López-de-Andrés A, Perez-Farinos N, de Miguel-Díez J, Hernández-Barrera V, Méndez-Bailón M, de Miguel-Yanes JM, et al. Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001–2015). Cardiovasc Diabetol. 2018;17:135.CrossRefPubMedPubMedCentral López-de-Andrés A, Perez-Farinos N, de Miguel-Díez J, Hernández-Barrera V, Méndez-Bailón M, de Miguel-Yanes JM, et al. Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001–2015). Cardiovasc Diabetol. 2018;17:135.CrossRefPubMedPubMedCentral
10.
go back to reference Natorska J, Wypasek E, Grudzień G, Sobczyk D, Marek G, Filip G, et al. Does Diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? Inflammation. 2012;35:834–40.CrossRefPubMed Natorska J, Wypasek E, Grudzień G, Sobczyk D, Marek G, Filip G, et al. Does Diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? Inflammation. 2012;35:834–40.CrossRefPubMed
11.
go back to reference Lee M-K, Han K, Kim MK, Koh ES, Kim ES, Nam GE, et al. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep. 2020;10:2313.CrossRefPubMedPubMedCentral Lee M-K, Han K, Kim MK, Koh ES, Kim ES, Nam GE, et al. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep. 2020;10:2313.CrossRefPubMedPubMedCentral
12.
go back to reference Greenberg HZE, Zhao G, Shah AM, Zhang M. Role of oxidative stress in calcific aortic valve disease and its therapeutic implications. Cardiovasc Res. 2022;118:1433–51.CrossRefPubMed Greenberg HZE, Zhao G, Shah AM, Zhang M. Role of oxidative stress in calcific aortic valve disease and its therapeutic implications. Cardiovasc Res. 2022;118:1433–51.CrossRefPubMed
13.
go back to reference Kopytek M, Ząbczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. 2020;19:92.CrossRefPubMedPubMedCentral Kopytek M, Ząbczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. 2020;19:92.CrossRefPubMedPubMedCentral
14.
go back to reference Bienjonetti-Boudreau D, Fleury M-A, Voisine M, Paquin A, Chouinard I, Tailleur M, et al. Impact of sex on the management and outcome of aortic stenosis patients. Eur Heart J. 2021;42:2683–91.CrossRefPubMed Bienjonetti-Boudreau D, Fleury M-A, Voisine M, Paquin A, Chouinard I, Tailleur M, et al. Impact of sex on the management and outcome of aortic stenosis patients. Eur Heart J. 2021;42:2683–91.CrossRefPubMed
15.
16.
go back to reference Matilla L, Garaikoetxea M, Arrieta V, García-Peña A, Fernández-Celis A, Navarro A et al. Sex-differences in aortic stenosis: mechanistic insights and clinical implications. Front Cardiovasc Med. 2022;9. Matilla L, Garaikoetxea M, Arrieta V, García-Peña A, Fernández-Celis A, Navarro A et al. Sex-differences in aortic stenosis: mechanistic insights and clinical implications. Front Cardiovasc Med. 2022;9.
17.
go back to reference Matilla L, Martín-Núñez E, Garaikoetxea M, Navarro A, Vico JA, Arrieta V et al. Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis. Front Cardiovasc Med. 2022;9. Matilla L, Martín-Núñez E, Garaikoetxea M, Navarro A, Vico JA, Arrieta V et al. Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis. Front Cardiovasc Med. 2022;9.
18.
go back to reference Garaikoetxea M, Martín-Núñez E, Navarro A, Matilla L, Fernández-Celis A, Arrieta V, et al. Targeting fatty acid-binding protein 4 improves pathologic features of aortic stenosis. Int J Mol Sci. 2022;23:8439.CrossRefPubMedPubMedCentral Garaikoetxea M, Martín-Núñez E, Navarro A, Matilla L, Fernández-Celis A, Arrieta V, et al. Targeting fatty acid-binding protein 4 improves pathologic features of aortic stenosis. Int J Mol Sci. 2022;23:8439.CrossRefPubMedPubMedCentral
19.
go back to reference Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2014;37:81–90.CrossRef Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2014;37:81–90.CrossRef
20.
go back to reference Sádaba JR, Martínez-Martínez E, Arrieta V, Álvarez V, Fernández‐Celis A, Ibarrola J et al. Role for Galectin‐3 in calcific aortic valve stenosis. J Am Heart Assoc. 2016;5. Sádaba JR, Martínez-Martínez E, Arrieta V, Álvarez V, Fernández‐Celis A, Ibarrola J et al. Role for Galectin‐3 in calcific aortic valve stenosis. J Am Heart Assoc. 2016;5.
21.
go back to reference Frühbeck G, Catalán V, Rodríguez A, Ramírez B, Becerril S, Salvador J, et al. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017;7:6619.CrossRefPubMedPubMedCentral Frühbeck G, Catalán V, Rodríguez A, Ramírez B, Becerril S, Salvador J, et al. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017;7:6619.CrossRefPubMedPubMedCentral
22.
go back to reference Vega GL, Grundy SM. Metabolic risk susceptibility in men is partially related to Adiponectin/Leptin ratio. J Obes. 2013;2013:1–9.CrossRef Vega GL, Grundy SM. Metabolic risk susceptibility in men is partially related to Adiponectin/Leptin ratio. J Obes. 2013;2013:1–9.CrossRef
23.
go back to reference Frühbeck G, Catalán V, Rodríguez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7:57–62.CrossRefPubMed Frühbeck G, Catalán V, Rodríguez A, Gómez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7:57–62.CrossRefPubMed
24.
go back to reference Matilla L, Jover E, Garaikoetxea M, Martín-Nuñez E, Arrieta V, García-Peña A, et al. Sex-related signaling of Aldosterone/Mineralocorticoid receptor pathway in calcific aortic stenosis. Hypertension. 2022;79:1724–37.CrossRefPubMed Matilla L, Jover E, Garaikoetxea M, Martín-Nuñez E, Arrieta V, García-Peña A, et al. Sex-related signaling of Aldosterone/Mineralocorticoid receptor pathway in calcific aortic stenosis. Hypertension. 2022;79:1724–37.CrossRefPubMed
25.
go back to reference Kayama Y, Raaz U, Jagger A, Adam M, Schellinger I, Sakamoto M, et al. Diabetic Cardiovascular Disease Induced by oxidative stress. Int J Mol Sci. 2015;16:25234–63.CrossRefPubMedPubMedCentral Kayama Y, Raaz U, Jagger A, Adam M, Schellinger I, Sakamoto M, et al. Diabetic Cardiovascular Disease Induced by oxidative stress. Int J Mol Sci. 2015;16:25234–63.CrossRefPubMedPubMedCentral
26.
go back to reference Kim K-M, Kim D-Y, Lee D-S, Kim J-W, Koh J-T, Kim E-J, et al. Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation. Exp Mol Med. 2019;51:1–11.PubMedPubMedCentral Kim K-M, Kim D-Y, Lee D-S, Kim J-W, Koh J-T, Kim E-J, et al. Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation. Exp Mol Med. 2019;51:1–11.PubMedPubMedCentral
27.
go back to reference Natorska J. Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications. Kardiol Pol. 2021;79:1060–7.CrossRefPubMed Natorska J. Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications. Kardiol Pol. 2021;79:1060–7.CrossRefPubMed
29.
go back to reference Khan MS, Tabrez S, Rabbani N, Shah A. Oxidative stress mediated cytotoxicity of Glycated Albumin: comparative analysis of glycation by glucose metabolites. J Fluoresc. 2015;25:1721–6.CrossRefPubMed Khan MS, Tabrez S, Rabbani N, Shah A. Oxidative stress mediated cytotoxicity of Glycated Albumin: comparative analysis of glycation by glucose metabolites. J Fluoresc. 2015;25:1721–6.CrossRefPubMed
30.
go back to reference Saku K, Tahara N, Takaseya T, Otsuka H, Takagi K, Shojima T et al. Pathological role of receptor for Advanced Glycation End Products in calcified aortic valve stenosis. J Am Heart Assoc. 2020;9. Saku K, Tahara N, Takaseya T, Otsuka H, Takagi K, Shojima T et al. Pathological role of receptor for Advanced Glycation End Products in calcified aortic valve stenosis. J Am Heart Assoc. 2020;9.
31.
go back to reference Kay AM, Simpson CL, Stewart JA. The role of AGE/RAGE signaling in diabetes-mediated vascular calcification. J Diabetes Res. 2016;2016:1–8.CrossRef Kay AM, Simpson CL, Stewart JA. The role of AGE/RAGE signaling in diabetes-mediated vascular calcification. J Diabetes Res. 2016;2016:1–8.CrossRef
32.
go back to reference Hofmann B, Yakobus Y, Indrasari M, Nass N, Santos AN, Kraus FB, et al. RAGE influences the development of aortic valve stenosis in mice on a high fat diet. Exp Gerontol. 2014;59:13–20.CrossRefPubMed Hofmann B, Yakobus Y, Indrasari M, Nass N, Santos AN, Kraus FB, et al. RAGE influences the development of aortic valve stenosis in mice on a high fat diet. Exp Gerontol. 2014;59:13–20.CrossRefPubMed
33.
34.
35.
go back to reference Kopytek M, Mazur P, Ząbczyk M, Undas A, Natorska J. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification. Diabetologia. 2021;64:2562–74.CrossRefPubMedPubMedCentral Kopytek M, Mazur P, Ząbczyk M, Undas A, Natorska J. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification. Diabetologia. 2021;64:2562–74.CrossRefPubMedPubMedCentral
36.
go back to reference Mourino-Alvarez L, Corbacho-Alonso N, Sastre-Oliva T, Corros-Vicente C, Solis J, Tejerina T, et al. Diabetes Mellitus and its implications in aortic stenosis patients. Int J Mol Sci. 2021;22:6212.CrossRefPubMedPubMedCentral Mourino-Alvarez L, Corbacho-Alonso N, Sastre-Oliva T, Corros-Vicente C, Solis J, Tejerina T, et al. Diabetes Mellitus and its implications in aortic stenosis patients. Int J Mol Sci. 2021;22:6212.CrossRefPubMedPubMedCentral
37.
go back to reference Mosch J, Gleissner CA, Body S, Aikawa E. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus. Histol Histopathol. 2017;32:293–306.PubMed Mosch J, Gleissner CA, Body S, Aikawa E. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus. Histol Histopathol. 2017;32:293–306.PubMed
38.
go back to reference Kolasa-Trela R, Miszalski-Jamka T, Grudzień G, Wypasek E, Kostkiewicz M. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease. Pol Arch Med Wewn. 2011;121:352–9.PubMed Kolasa-Trela R, Miszalski-Jamka T, Grudzień G, Wypasek E, Kostkiewicz M. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease. Pol Arch Med Wewn. 2011;121:352–9.PubMed
39.
go back to reference Mohty D, Pibarot P, Côté N, Cartier A, Audet A, Després JP, et al. Hypoadiponectinemia is Associated with valvular inflammation and faster Disease Progression in patients with aortic stenosis. Cardiology. 2011;118:140–6.CrossRefPubMed Mohty D, Pibarot P, Côté N, Cartier A, Audet A, Després JP, et al. Hypoadiponectinemia is Associated with valvular inflammation and faster Disease Progression in patients with aortic stenosis. Cardiology. 2011;118:140–6.CrossRefPubMed
40.
go back to reference López-Jaramillo P, Gómez-Arbeláez D, López-López J, López-López C, Martínez-Ortega J, Gómez-Rodríguez A et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Investig. 2014;18. López-Jaramillo P, Gómez-Arbeláez D, López-López J, López-López C, Martínez-Ortega J, Gómez-Rodríguez A et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Investig. 2014;18.
Metadata
Title
Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach
Authors
Ernesto Martín-Núñez
Miriam Goñi-Olóriz
Lara Matilla
Mattie Garaikoetxea
Laura Mourino-Alvarez
Adela Navarro
Amaya Fernández-Celis
Ibai Tamayo
Alicia Gainza
Virginia Álvarez
Rafael Sádaba
María G. Barderas
Eva Jover
Natalia López-Andrés
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Diabetes
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02009-w

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine